Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Fesoterodine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 6,080Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Health Canada Issues Recall of Sandoz's Fesoterodine Fumarate
    Health Canada Issues Recall of Sandoz's Fesoterodine Fumarate

    16 May 2024

    // HEALTH CANADA

    https://recalls-rappels.canada.ca/en/alert-recall/sandoz-fesoterodine-fumarate-8-mg-tablet-out-specification-diester-impurity

    HEALTH CANADA
    16 May 2024
    Share Share
    Hetero`s Generic Fesoterodine Fumarate Receives Approval in the U.S.
    Hetero`s Generic Fesoterodine Fumarate Receives Approval in the U.S.

    09 Jan 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204792

    FDA
    09 Jan 2024
    Share Share
    Lupin's Generic Fesoterodine Fumarate Receives Approval in the U.S.
    Lupin's Generic Fesoterodine Fumarate Receives Approval in the U.S.

    05 Jan 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204983

    FDA
    05 Jan 2023
    Share Share
    Accord healthcare's Generic Fesoterodine Fumarate Receives Approval in U.S.
    Accord healthcare's Generic Fesoterodine Fumarate Receives Approval in U.S.

    04 Jan 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205012

    FDA
    04 Jan 2023
    Share Share
    ANI Pharm's Generic Fesoterodine Fumarate Receives Approval in U.S.
    ANI Pharm's Generic Fesoterodine Fumarate Receives Approval in U.S.

    04 Jan 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204504

    FDA
    04 Jan 2023
    Share Share
    Actavis Lab's Generic Fesoterodine Fumarate Receives Approval in U.S.
    Actavis Lab's Generic Fesoterodine Fumarate Receives Approval in U.S.

    04 Jan 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204868

    FDA
    04 Jan 2023
    Share Share